Evidence map›Paper›PMID 40325182›Full record

ArticleOncogene2025

Functional mitochondrial respiration is essential for glioblastoma tumour growth.

Petra Brisudova, Dana Stojanovic, Jaromir Novak, Zuzana Nahacka, Gabriela Lopes Oliveira, Ondrej Vanatko, Sarka Dvorakova, Berwini Endaya, Jaroslav Truksa, Monika Kubiskova and 17 more

Erratum issuedAbstract read
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Coupling proteostasis andTheranostics · 2026
    Article
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Petra BrisudovaInstitute of Biotechnology, Czech Academy of Sciences, 252 50, Vestec, Czech Republic.ORCID http://orcid.org/0009-0001-9751-9356
Dana StojanovicInstitute of Biotechnology, Czech Academy of Sciences, 252 50, Vestec, Czech Republic.
Jaromir NovakInstitute of Biotechnology, Czech Academy of Sciences, 252 50, Vestec, Czech Republic.ORCID http://orcid.org/0000-0001-5851-9399
Zuzana NahackaInstitute of Biotechnology, Czech Academy of Sciences, 252 50, Vestec, Czech Republic.
Gabriela Lopes OliveiraInstitute of Biotechnology, Czech Academy of Sciences, 252 50, Vestec, Czech Republic.ORCID http://orcid.org/0000-0001-5258-3322
Ondrej VanatkoInstitute of Experimental Medicine, Czech Academy of Sciences, 142 00, Prague 4, Czech Republic.
Sarka DvorakovaInstitute of Biotechnology, Czech Academy of Sciences, 252 50, Vestec, Czech Republic.
Berwini EndayaInstitute of Biotechnology, Czech Academy of Sciences, 252 50, Vestec, Czech Republic.ORCID http://orcid.org/0000-0002-4072-4332
Jaroslav TruksaInstitute of Biotechnology, Czech Academy of Sciences, 252 50, Vestec, Czech Republic.
Monika KubiskovaInstitute of Experimental Medicine, Czech Academy of Sciences, 142 00, Prague 4, Czech Republic.
Alice FoltynovaInstitute of Experimental Medicine, Czech Academy of Sciences, 142 00, Prague 4, Czech Republic.
Daniel JirakInstitute of Clinical and Experimental Medicine, 140 21, Prague 4, Czech Republic.ORCID http://orcid.org/0000-0001-6834-3462
Natalia Jirat-ZiolkowskaInstitute of Clinical and Experimental Medicine, 140 21, Prague 4, Czech Republic.
Lukas KuceraCzech Centre for Phenogenomics, Institute of Molecular Genetics, Czech Academy of Sciences, 142 20, Prague 4, Czech Republic.ORCID http://orcid.org/0000-0002-0009-5105
Karel ChalupskyCzech Centre for Phenogenomics, Institute of Molecular Genetics, Czech Academy of Sciences, 142 20, Prague 4, Czech Republic.
Krystof KlimaCzech Centre for Phenogenomics, Institute of Molecular Genetics, Czech Academy of Sciences, 142 20, Prague 4, Czech Republic.
Jan ProchazkaCzech Centre for Phenogenomics, Institute of Molecular Genetics, Czech Academy of Sciences, 142 20, Prague 4, Czech Republic.
Radislav SedlacekCzech Centre for Phenogenomics, Institute of Molecular Genetics, Czech Academy of Sciences, 142 20, Prague 4, Czech Republic.ORCID http://orcid.org/0000-0002-3352-392X
Francesco MengarelliDepartment of Life and Environmental Sciences, Polytechnic University of Marche, 60131, Ancona, Italy.
Patrick OrlandoDepartment of Life and Environmental Sciences, Polytechnic University of Marche, 60131, Ancona, Italy.
Luca TianoDepartment of Life and Environmental Sciences, Polytechnic University of Marche, 60131, Ancona, Italy.
Paulo J OliveiraCNC-UC, Center for Neuroscience and Cell Biology, University of Coimbra, 3060-197, Cantanhede, Portugal.
Carole GrassoMalaghan Institute of Medical Research, Wellington, 6242, New Zealand.
Michael V BerridgeMalaghan Institute of Medical Research, Wellington, 6242, New Zealand.ORCID http://orcid.org/0000-0003-2619-7473
Renata ZobalovaInstitute of Biotechnology, Czech Academy of Sciences, 252 50, Vestec, Czech Republic. renata.zobalova@ibt.cas.cz.ORCID http://orcid.org/0000-0002-9097-4700
Miroslava AnderovaInstitute of Experimental Medicine, Czech Academy of Sciences, 142 00, Prague 4, Czech Republic. miroslava.anderova@iem.cas.cz.
Jiri NeuzilInstitute of Biotechnology, Czech Academy of Sciences, 252 50, Vestec, Czech Republic. jiri.neuzil@ibt.cas.cz.ORCID http://orcid.org/0000-0002-2478-2460

Funding

Agentura Pro Zdravotnický Výzkum České Republiky (Czech Health Research Council) NU23-03-00226Grantová Agentura České Republiky (Grant Agency of the Czech Republic) GA20-05942SGrantová Agentura České Republiky (Grant Agency of the Czech Republic) GF24-10406K
6 · The paper itself

Abstract

Horizontal transfer of mitochondria from the tumour microenvironment to cancer cells to support proliferation and enhance tumour progression has been shown for various types of cancer in recent years. Glioblastoma, the most aggressive adult brain tumour, has proven to be no exception when it comes to dynamic intercellular mitochondrial movement, as shown in this study using an orthotopic tumour model of respiration-deficient glioblastoma cells. Although confirmed mitochondrial transfer was shown to facilitate tumour progression in glioblastoma, we decided to investigate whether the related electron transport chain recovery is necessary for tumour formation in the brain. Based on experiments using time-resolved analysis of tumour formation by glioblastoma cells depleted of their mitochondrial DNA, we conclude that functional mitochondrial respiration is essential for glioblastoma growth in vivo, because it is needed to support coenzyme Q redox cycling for de novo pyrimidine biosynthesis controlled by respiration-linked dihydroorotate dehydrogenase enzyme activity. We also demonstrate here that astrocytes are key mitochondrial donors in this model.

Indexed as

Brain NeoplasmsGlioblastomaMitochondriaAnimalsAstrocytesCell Line, TumorCell ProliferationCell RespirationDihydroorotate DehydrogenaseDNA, MitochondrialElectron TransportHumansMiceOxidoreductases Acting on CH-CH Group DonorsUbiquinoneDihydroorotate DehydrogenaseDNA, MitochondrialOxidoreductases Acting on CH-CH Group DonorsUbiquinone

Identifiers

PMID40325182
PMCPMC12277175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.